Yes, marijuana use can cause dizziness.
Cannabis products are associated with increased risk for dizziness and sedation, as documented in recent high-quality guidelines and FDA-approved drug labels. 1
Evidence from Guidelines and Drug Labels
The 2024 American College of Physicians position paper on cannabis explicitly states that a 2022 meta-analysis concluded cannabis products "may be associated with short-term improvements in chronic pain and increased risk for dizziness and sedation" 1. This represents the most recent guideline-level evidence directly addressing dizziness as an adverse effect.
The FDA-approved drug label for Cesamet (nabilone), a synthetic cannabinoid, lists vertigo/dizziness as occurring in 59% of patients (147 out of 250 patients) in active-controlled studies, compared to only 23% with prochlorperazine 2. The label explicitly warns that patients should "remain under supervision of a responsible adult" and "not drive, operate machinery, or engage in any hazardous activity" due to CNS effects including dizziness 2.
Mechanism and Clinical Presentation
The dizziness from cannabis occurs through multiple mechanisms:
- Orthostatic hypotension: Cannabis causes supine and orthostatic blood pressure drops, with elevated heart rates 2
- Cerebral blood flow alterations: Studies demonstrate marked decreases in cerebral blood velocity during upright posture after marijuana use, with 28% of users reporting severe postural dizziness 3, 4
- Direct vestibular effects: CB1 cannabinoid receptors exist in the vestibular nucleus complex and may directly affect balance function 5
Risk Factors and Severity
Older adults face particularly high risk. Acute cannabis toxicity in older adults may be associated with sedation, obtundation, and cardiovascular complications 1. The 2024 ASCO guideline on cannabis in cancer patients emphasizes that "to minimize adverse effects, particularly in older adults and in those naïve to cannabis and/or cannabinoids, products should be started at a low dose and slowly increased" 6.
Common adverse effects include:
- Dizziness (very common, up to 59% in clinical trials)
- Confusion and disorientation
- Dry mouth
- Fatigue
- Tachycardia and orthostatic hypotension 2
Clinical Pitfalls
The severity of dizziness is dose-dependent and related to THC concentration. Average THC concentration in cannabis plants nearly doubled from 9% in 2008 to 17% in 2017, with concentrates reaching 70% THC 1. Higher potency products carry greater risk for adverse effects including severe dizziness.
Postural symptoms are particularly problematic. Six of 10 subjects in one study reported moderate to severe dizziness during standing after marijuana, with those experiencing severe dizziness showing marked decreases in blood pressure and cerebral blood velocity 4. This represents a significant fall risk.
Synthetic cannabinoids carry even higher toxicity rates than natural cannabis, with dizziness and vertigo among the most commonly reported toxicities 7.
Patient Counseling Points
Patients using cannabis should be warned about:
- High likelihood of dizziness, especially with position changes
- Increased fall risk, particularly in older adults
- Additive effects with alcohol, benzodiazepines, barbiturates, and other CNS depressants 2
- Need for supervision by a responsible adult during use
- Avoidance of driving and operating machinery
The dizziness typically peaks immediately after drug administration and is unrelated to plasma THC levels 3, making it unpredictable based on dosing alone.